India's Jubilant Weighs Singapore IPO of Pharma Unit

Jubilant Life Sciences Ltd., a roughly $2 billion India-based drug company, is considering a Singapore initial public offering of its pharmaceuticals subsidiary, according to people with knowledge of the matter. Singapore-based Jubilant Pharma Ltd. has …
( read original story …)


Search your Hotel